Literature DB >> 1777549

Effect of omeprazole on intestinal output in the short bowel syndrome.

J M Nightingale1, E R Walker, M J Farthing, J E Lennard-Jones.   

Abstract

Ten patients with an end jejunostomy and one with a jejuno-rectal anastomosis (jejunal length 30-140 cm) ate a constant chosen diet for 2 control days, and 2 test days when 40 mg omeprazole orally was taken each morning. In the 7 patients with a net secretory output of fluid, there was a mean reduction in wet weight of 0.66 kg/24 h (range -0.16 to 1.45 kg/24 h; P less than 0.05) and sodium 46 mmol/24 h (-51 to 135 mmol/24 h; N.S.); the four patients with net absorption of fluid showed no reduction in intestinal output. One patient with 30 cm jejunum responded little to oral but did so to intravenous 40 mg omeprazole twice a day with a reduction in wet weight of 3.00 kg/24 h and sodium 157 mmol/24 h. In one patient oral 40 mg omeprazole daily gave equivalent results to oral 300 mg ranitidine twice daily; in 2 others it was equivalent to intravenous 50 micrograms octreotide twice daily. Omeprazole reduces the intestinal output in patients with the short bowel syndrome and a net secretory output, but not enough to prevent the need for parenteral fluid and electrolyte replacement.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777549     DOI: 10.1111/j.1365-2036.1991.tb00044.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

1.  Guidelines for management of patients with a short bowel.

Authors:  J Nightingale; J M Woodward
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

2.  Complications of enterocutaneous fistulas and their management.

Authors:  Lara J Williams; Shahram Zolfaghari; Robin P Boushey
Journal:  Clin Colon Rectal Surg       Date:  2010-09

3.  The short bowel syndrome: underdiagnosis or undertreatment?

Authors:  M A Stokes; T F Gorey
Journal:  Ir J Med Sci       Date:  1994-02       Impact factor: 1.568

Review 4.  Short bowel syndrome in children: current and potential therapies.

Authors:  Victor Uko; Kadakkal Radhakrishnan; Naim Alkhouri
Journal:  Paediatr Drugs       Date:  2012-06-01       Impact factor: 3.022

Review 5.  Management of patients with a short bowel.

Authors:  J M Nightingale
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

6.  Ileostomy diarrhea.

Authors:  Andrew W DuPont; Joseph H Sellin
Journal:  Curr Treat Options Gastroenterol       Date:  2006-02

7.  Management of enterocutaneous fistulas.

Authors:  Manish Kaushal; Gordon L Carlson
Journal:  Clin Colon Rectal Surg       Date:  2004-05

8.  Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection.

Authors:  P B Jeppesen; M Staun; L Tjellesen; P B Mortensen
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

Review 9.  Octreotide in the treatment of refractory diarrhoea and intestinal fistulae.

Authors:  M J Farthing
Journal:  Gut       Date:  1994       Impact factor: 23.059

Review 10.  The pharmacologic treatment of short bowel syndrome: new tricks and novel agents.

Authors:  Matthew L Bechtold; Stephen A McClave; Lena B Palmer; Douglas L Nguyen; Lindsay M Urben; Robert G Martindale; Ryan T Hurt
Journal:  Curr Gastroenterol Rep       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.